1d
Fintel on MSNCanaccord Genuity Initiates Coverage of Palvella Therapeutics (PVLA) with Buy RecommendationFintel reports that on February 20, 2025, Canaccord Genuity initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with ...
2d
Hosted on MSNCanaccord Genuity Initiates Coverage of Candel Therapeutics (CADL) with Buy RecommendationFintel reports that on February 19, 2025, Canaccord Genuity initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a ...
Canaccord Genuity analyst Alexander Bedwany maintained a Buy rating on Taseko Mines (TGB – Research Report) today and set a price target of ...
Analysts at Canaccord Genuity lowered their target price on exploration and production firm Tullow Oil from 35.0p to 25.0p ...
Analysts at Canaccord Genuity reiterated their 'buy' rating on package holidays business Jet2, noting that the group has been ...
SharkNinja (NYSE:SN – Free Report) had its price target increased by Canaccord Genuity Group from $129.00 to $136.00 in a ...
Canaccord Genuity analyst Paul Buys maintained a Hold rating on HUB24 Limited (FSB – Research Report) yesterday and set a price target of ...
MP Materials Corp. (NYSE: MP) today announced that Ryan Corbett, Chief Financial Officer, will participate in the Canaccord ...
Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...
PITTSBURGH, February 12, 2025--(BUSINESS WIRE)--Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results